Work

STK11 Loss Stabilizes MCL1 and Confers Targetable Drug Resistance in KRAS Mutant NSCLC

Year: 2017

Type: conference-abstract

Source: The FASEB Journal

DOI: 10.1096/fasebj.31.1_supplement.lb531

Authors: Michael Kahle, Esra Akbay, Camilla Christensen, Lynette Sholl, Jeffrey Becker, Margaret Soucheray, Zhao Chen, Ines Pulido, Eiki Kikuchi, Yandi Gao, Peter Dennis, Wei Qiu, Fatima Al‐Shahrour, Neil Johnson, Mark Awad, Julian Carretero, Kwok‐Kin Wong, Takeshi Shimamura

Institutions: Loyola University Chicago, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard University, Universitat de València, Hokkaido University Hospital, Spanish National Cancer Research Centre, Fox Chase Cancer Center

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: American Cancer Society, Ministerio de Economía y Competitividad, Generalitat Valenciana, National Institutes of Health, Instituto de Salud Carlos III

Awards: G5309232169, G5825203155, G603575285, G6616021960, G7414695298, G9000058809, G9000110333, G9000117989, G9000165009

OpenAlex ID: W4389020459

Cites:

Cited by:

Related to: 10